Preferred Label : Eladocagene exuparvovec;
MeSH synonym : Eladocagene exuparvovec-tneq; Kebildi;
Origin ID : C000731825;
ATC code(s)
- MeSH term(s) associated for indexing
- Record concept(s)
- Validated automatic mappings to BTNT
https://www.has-sante.fr/jcms/p_3840501/fr/upstaza-eladocagene-exuparvovec-maladie-rare
2026
false
false
false
France
insurance, health, reimbursement
summary of product characteristics
package leaflet
Eladocagene Exuparvovec
genetic vectors
child
infant
aromatic amino acid decarboxylase deficiency
gene therapy
orphan drug production
eladocagene exuparvovec
Eladocagene exuparvovec
drug information
---
https://ansm.sante.fr/tableau-marr/eladocagene-exuparvovec
2025
false
false
false
France
French
risk management
guidelines for drug use
Eladocagene Exuparvovec
drug compounding
Stereotactic surgery
stereotaxic techniques
gene therapy
Intraputaminal Route of Administration
aromatic amino acid decarboxylase deficiency
Injection of brain (procedure)
infusions, parenteral
neurosurgical procedures
patient education handout
guideline
eladocagene exuparvovec
Eladocagene exuparvovec
---
https://ansm.sante.fr/tableau-acces-derogatoire/upstaza
2025
false
false
false
France
French
Eladocagene Exuparvovec
drug information
infant
Aromatic-L-Amino-Acid decarboxylases
Aromatic-L-Amino-Acid Decarboxylase
aromatic amino acid decarboxylase deficiency
technical report
Eladocagene exuparvovec
---
https://www.has-sante.fr/jcms/p_3402378/fr/upstaza-eladocagene-exuparvovec-deficit-en-decarboxylase-d-acide-l-amine-aromatique
2022
false
false
false
France
insurance, health, reimbursement
treatment outcome
child
infant
Eladocagene Exuparvovec
gene therapy
amino acid metabolism, inborn errors
Aromatic-L-Amino-Acid decarboxylases
infusions, parenteral
Intraputaminal Route of Administration
eladocagene exuparvovec
Eladocagene exuparvovec
evaluation of the transparency committee
aromatic amino acid decarboxylase deficiency
---
https://www.has-sante.fr/jcms/p_3398547/fr/upstaza-eladocagene-exuparvovec-maladie-rare
2022
false
false
false
France
Eladocagene exuparvovec
evaluation of the transparency committee
rare diseases
Diseases
Rare disease
disease, nos
---
https://www.ema.europa.eu/en/medicines/human/EPAR/upstaza
2022
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
Eladocagene Exuparvovec
aromatic amino acid decarboxylase deficiency
gene therapy
infant
child
drug approval
europe
amino acid metabolism, inborn errors
infusions, parenteral
Aromatic-L-Amino-Acid decarboxylases
orphan drug production
risk management
product surveillance, postmarketing
adolescent
adult
aromatic amino acid decarboxylase deficiency
genetic testing
Intraputaminal Route of Administration
eladocagene exuparvovec
Eladocagene exuparvovec
Eladocagene exuparvovec
---
